Edwards Lifesciences gains on upbeat 2026 profit outlook

Edwards Lifesciences

10/02/2026 21:45

** Shares of medical device maker Edwards Lifesciences EW.N up 3.3% at $79.60 after the bell

** EW forecasts 2026 profit above estimates, betting on robust demand for its artificial heart valves and other medical devices

** Expects 2026 adjusted profit to be in the range of $2.90 to $3.05 per share vs estimate of $2.89 per share — data compiled by LSEG

** Posts Q4 net sales of $1.57 billion vs estimates of $1.55 billion

** In 2025, EW shares rose 15.2%

(Reporting by Sumit Saha in Bengaluru)

((Sumit.Saha@thomsonreuters.com))